A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

PHASE2TerminatedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

February 13, 2023

Study Completion Date

March 6, 2023

Conditions
Palmoplantar Pustulosis
Interventions
DRUG

RIST4721

RIST4721 tablets, 100 mg are blue, oval, biconvex film-coated tablets

DRUG

Placebo

Matching placebo

Trial Locations (51)

1085

Semmelweis University, Department of Dermatology, Venerology and Dermatooncology, Budapest

4012

University of Debrecen, Dermatology Department, Debrecen

6000

Bács-Kiskun Megyei KórházSzegedi Tudományegyetem Általános Orvostudományi Kar Oktató Kórháza Bórgyógyászati Szakrendelés, Kecskemét

7632

University of Pecs, Department of Dermatology, Venerology and Oncodermatology, Pécs

15212

UPMC Department of Dermatology, Pittsburgh

15831

Hautarztpraxis Mahlow, Mahlow

20537

TFS Trial Form Support GmbH SCIderm - Zentrum für klinische Studien, Hamburg

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel [Zentrum für entzundliche Hauterkrankungen] Klinik für Dermatologie, Venerologie und Allergologie, Kiel

30328

Advanced Medical Research PC, Sandy Springs

33021

Encore Medical Research, LLC, Hollywood

33134

Driven Research LLC, Coral Gables

33162

Tory Sullivan, MD PA, North Miami Beach

35205

Total Skin & Beauty Dermatology Center, PC, Birmingham

40241

DS Research, Louisville

43016

Aventiv Research Inc., Dublin

44124

Apex Clinical Research Center, Mayfield Heights

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48149

Universitaetsklinikum Muenster, Münster

48455

Fachklinik Bad Bentheim Fachbereich Dermatologie und Allergologie, Bad Bentheim

48706

Great Lakes Research Group, Inc., Bay City

49074

KliFOs - Klinische Forschung Osnabrück, Osnabrück

63108

Washington University School of Medicine-Dermatology, St Louis

68144

Skin Specialists, PC (Schlessinger MD), Omaha

70178

Hautarztpraxis Dres. Leitz & Kollegen, Stuttgart

72022

Dermatology Trial Associates, Bryant

73071

Central Sooner Research, Norman

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

80337

Klinikum der Universität München Klinik und Poliklinik der Dermatologie und Allergologie Der Universität München, München

86156

Universitätsklinikum Augsburg Klinik für Dermatologie und Allergologie, Augsburg

90404

Clinical Science Institute, Santa Monica

91054

Universitätsklinikum Erlangen Hautklinik, Erlangen

92121

Cosmetic Laser Dermatology, San Diego

03801

ALLCUTIS Research, LLC., Portsmouth

T6G 1C3

Alberta DermaSurgery Centre, Edmonton

T6H 4JB

Vida Dermatology, Edmonton

T4P 1K4

Central Alberta Research Clinic (CARe Clinic), Red Deer

L4M 7G1

SimcoDerm Medical and Surgical, Barrie

L3P 1X3

Lynderm Research Inc., Markham

G1V 4X7

Centre De Recherche Dermatologique Du Quebec Metropolitan Inc., Québec

284 01

Kožní ambulance Kutná Hora, s.r.o., Kutná Hora

100 00

Clintrial s.r.o, Prague

150 00

Praglandia s.r.o., Prague

01307

Uniklinikum Dresden Klinik und Poliklinik für Dermatologie, Dresden

31-559

Diamond Clinic Spolka z ograniczona odpowiedzialnoscia, Krakow

20-078

Clinical Best Solutions, Lublin

20-573

Luxderm Specjalistyczny Gabinet Dermatologiczny, Lublin

01-142

Luxderm Specjalistyczny Gabinet Dermatologiczny, Warsaw

02-962

Royalderm Agnieszka Nawrocka, Warsaw

50-566

Przychodnia Lekarsko-Psychologinczna Matusiak Spółka Partnerska, Wroclaw

51-318

DermMedica Sp. z o.o., Wroclaw

M6 8HD

Salford Care Organisation, Salford

Sponsors
All Listed Sponsors
lead

Aristea Therapeutics, Inc.

INDUSTRY

NCT05194839 - A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) | Biotech Hunter | Biotech Hunter